The LEGACY Girls Study, a study taking place across five sites in North America, is the first to focus on preadolescent girls growing up in families with breast cancer risk.
Funded by the National Cancer Institute, the LEGACY study is unique in its focus on healthy, young girls and how their habits and development are related to breast health.
This is the first generation where women are routinely tested for genetic mutations that may increase their risk for breast cancer. They are also increasingly aware of the implications of their cancer history and genetic testing results on their daughters.
Research and investigators from The Children's Hospital of Philadelphia Research Institute are often cited in a variety of news stories, columns, and investigative articles. Here are just a few of the recent news reports featuring investigators from CHOP Research: Skip the Supplements, Says Dr. Offit
Researchers from The Children's Hospital of Philadelphia and the University of Pennsylvania recently published a study in the Journal of the American Medical Association (JAMA) that shows differences in how breast cancer patients present at diagnosis are more responsible for racial disparities in 5-year survival than treatment disparities. Jeffrey H. Silber, MD, PhD, professor of Pediatrics, Anesthesiology and Critical Care
